Polpharma Group B.V.,Debutir 150 mg x 60 caps.,Debutir 150 mg x 60 kaps.

Designed for:
• diseases of the large intestine with atrophic changes in the mucous membrane,
• irritable bowel syndrome (IBS),
• malabsorption leading to nutritional deficiencies, weight loss or abnormal growth in children,
• functional gastrointestinal disorders such as: chronic constipation, abdominal pain, bloating, dyspepsia, diarrhea,
• nutritional deficiencies (insufficient dietary fiber, low fiber diet),
• disturbances of the intestinal flora, including: after long-term antibiotic therapy, in some chronic diseases (diseases of the pancreas, liver, kidneys).
PRODUCT DESCRIPTION/PURPOSE
DEBUTYR is a food product for special medical purposes in the form of capsules containing sodium butyrate in a mixture of acylglycerols (mono-, di- and triacylglycerols), coated with a sodium alginate shell. Thanks to the innovative coating formula, sodium butyrate reaches the colon.
HOW TO USE
• Adults: 1 capsule orally twice daily, morning and evening. It is recommended to use the drug for at least 3 months.
• Children over 7 years of age: 1 capsule per day orally, preferably in the evening. It is recommended to use the drug for at least 6 weeks.
The capsule should be swallowed whole (without chewing or spilling the contents) with warm or cool water. Best taken with food.
Depending on individual needs, your doctor may recommend other doses of the drug.
Store at temperatures below 25℃, out of the reach of small children. Keep away from moisture.